abstract |
The present invention provides compounds of the formula (I) and salts thereof as described herein, and therapeutic uses of these compounds for the treatment of disorders associated with Raf kinase activity. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and therapeutic co-agents. (I) |